Stay updated on Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.

Latest updates to the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference1%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check45 days agoChange DetectedThe page has been updated to include new information about neovascular age-related macular degeneration and a new version revision, while significant details about a clinical study have been removed.SummaryDifference13%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check60 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.